Trial intelligence / Profile preview

Intradialytic vitamin E and vitamin C in sepsis-associated acute kidney injury

2008-003887-21Phase 2Terminated

Sponsor
Univ.-Doz. Dr. Karl-Heinz Smolle
Start
Feb 2009
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 2 trial of vitamin e and ascorbic acid in acute kidney failure (AKF) and sepsis, sponsored by Univ.-Doz. Dr. Karl-Heinz Smolle. Primary endpoints: Biochemical indicators of antioxidant capacity and Inflammatory markers and proinflammatory cytokines. Started Feb 2009; status: terminated.

02

Drugs

vitamin eascorbic acid
03

Conditions

acute kidney failure (AKF)sepsis

Beyond the preview

Go deeper on 2008-003887-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-003887-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call